Once again UCSF had an impressive presence at this year's annual meeting of the American Society of Clinical Oncologists (ASCO) in Chicago. One of the world’s most prestigious gatherings of oncology professionals, ASCO 2019 drew more than 40,000 cancer experts focusing on groundbreaking research and ...

Dr. Lawrence Fong, leader of the HDFCCC Cancer Immunotherapy Program, was featured last month on the CureTalks podcast for a live discussion of the latest in cancer immunotherapy research, clinical trials, and treatments. Immunotherapy is a type of cancer treatment that helps your immune system ...

Tobacco and nicotine research have deep roots at UC San Francisco (UCSF) dating decades back to when the tobacco industry denied the risks of smoking, its causal effects of lung cancer, heart disease and other health problems. A rising number of faculty are dedicated to ...

Muscle damage is a common side effect of radiation therapy for cancer treatment, and is made worse because the very stem cells responsible for repairing injured muscles typically bear the brunt of radiation damage. Now UC San Francisco researchers have discovered a new type of ...

UC San Francisco cancer biologist Alan Ashworth, PhD, structural biologist Yifan Cheng, PhD, and molecular physiologist Holly Ingraham, PhD, have been elected to the American Academy of Arts and Sciences. Ashworth is president of the UCSF Helen Diller Family Comprehensive Cancer Center and E. Dixon Heise Distinguished Professor ...

Led by Dr. Emily Bergsland, Associate Director of Education for the Helen Diller Family Comprehensive Cancer Center, the Office of Education & Training (OET) aims to connect the UCSF cancer community with education, mentoring, and career development opportunities across all trainee levels. We sat down ...